AGBIO Diagnostics Overview

  • Founded
  • 1994
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 1

AGBIO Diagnostics General Information

Description

Developer of gene chip technology designed to detect human papillomavirus that is closely related to cervical cancer in a patient's body. The company's technology focuses on the area of enteric virus, drug resistance of tubercular bacillus and sexually transmitted disease diagnosis, enabling researchers to find a cost-effective treatment.

Contact Information

Formerly Known As
Biomedlab Co
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
  • Number 901, 551-17, Yangcheon-ro
  • Gangseo-gu (Gayang-dong, Hanwha Biz Metro 1st)
  • Seoul
  • South Korea
+82 00-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AGBIO Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC Completed Startup
To view AGBIO Diagnostics’s complete valuation and funding history, request access »

AGBIO Diagnostics Executive Team (1)

Name Title Board Seat Contact Info
Back Chul Chief Executive Officer
To view AGBIO Diagnostics’s complete executive team members history, request access »

AGBIO Diagnostics Board Members (1)

Name Representing Role Since
Jin Oh AGBIO Diagnostics Board Member 000 0000
To view AGBIO Diagnostics’s complete board members history, request access »

AGBIO Diagnostics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Korea Investment Partners Venture Capital Minority 000 0000 000000 0
To view AGBIO Diagnostics’s complete investors history, request access »